![](/img/cover-not-exists.png)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Butowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., Huse, J., Phillips, J., West, B. L., Nolop, K. B., Hsu, H. H., LLanguage:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nov245
Date:
October, 2015
File:
PDF, 296 KB
english, 2015